Author

Hideki Aizaki

National Institute of Infectious DiseasesORCID 0000-0002-8346-4729Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Atsushi Miyajima· 1 shared Atsuya Yamashita· 1 shared Haruyo Aoyagi· 1 shared Hiroshi SuemizuiD· 1 shared Hirotake Kasai· 1 shared Kaoru KobayashiiD· 1 shared Kohji MoriishiiD· 1 shared Kousho WakaeiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

Atsushi Miyajima

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Vorapaxar and aripiprazole suppress hepatitis B virus replication through distinct host signaling pathways

Atsuya Yamashita, Hirotake Kasai, Haruyo Aoyagi, Kousho Wakae, Kaoru Kobayashi, Atsushi Miyajima, Yuichiro Higuchi, Hiroshi Suemizu, Ryo Fukushima, Masanori Isogawa, Takaji Wakita, Hideki Aizaki, Kohji Moriishi

This paper identifies vorapaxar and aripiprazole as inhibitors of HBV replication through distinct host signaling pathways, showing their potential as host-targeting antivirals.

bioRxiv · Aug 9, 2026 · PreprintPharmacology & Toxicology